Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
COCP · net income · updated Jun 9, 2026
Core profitability metrics
COCP · net income · margin · TTM · CAGRNet income was −$8.8M for FY2025 (fiscal year ending 2025-12-31), up 49.5% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · COCP net income history · COCP profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Cocrystal Pharma, Inc. (COCP) reported net income of −$8.8M for FY2025 (fiscal year ending 2025-12-31), up 49.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Cocrystal Pharma, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.
Cocrystal Pharma, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Cocrystal Pharma, Inc. net worth" — the company's market capitalization is a separate figure from COCP net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
COCP net income · 4 questionsCocrystal Pharma, Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.8M for FY2025.
▸ Source: FMP /income-statement · GAAP · Cocrystal Pharma, Inc. · Cocrystal Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026